United Therapeutics [UTHR] vs Haleon Plc – ADR [HLN] Detailed Stock Comparison

United Therapeutics

NASDAQ

Haleon Plc - ADR

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: United Therapeutics wins in 14 metrics, Haleon Plc - ADR wins in 5 metrics, with 0 ties. United Therapeutics appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	United Therapeutics	Haleon Plc - ADR	Better
P/E Ratio (TTM)	11.76	21.44	United Therapeutics
Price-to-Book Ratio	1.90	5.44	United Therapeutics
Debt-to-Equity Ratio	0.00	53.41	United Therapeutics
PEG Ratio	1.23	22.98	United Therapeutics
EV/EBITDA	6.63	36.05	United Therapeutics
Profit Margin (TTM)	40.36%	13.81%	United Therapeutics
Operating Margin (TTM)	45.64%	22.21%	United Therapeutics
EBITDA Margin (TTM)	45.64%	22.21%	United Therapeutics
Return on Equity	19.30%	9.38%	United Therapeutics
Return on Assets (TTM)	12.96%	4.61%	United Therapeutics
Free Cash Flow (TTM)	$1.08B	$1.98B	Haleon Plc - ADR
Dividend Yield	N/A	1.63%	N/A
1-Year Return	-2.45%	-0.31%	Haleon Plc - ADR
Price-to-Sales Ratio (TTM)	4.43	3.96	Haleon Plc - ADR
Enterprise Value	$10.58B	$128.31B	Haleon Plc - ADR
EV/Revenue Ratio	3.44	8.59	United Therapeutics
Gross Profit Margin (TTM)	89.03%	55.38%	United Therapeutics
Revenue per Share (TTM)	$69	$2	United Therapeutics
Earnings per Share (Diluted)	$25.62	$0.45	United Therapeutics
Beta (Stock Volatility)	0.57	0.24	Haleon Plc - ADR

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

United Therapeutics vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
United Therapeutics	0.34%	3.86%	6.78%	3.03%	-16.01%	-13.07%
Haleon Plc - ADR	-0.52%	1.15%	-0.82%	-9.56%	-3.40%	2.22%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
United Therapeutics	-2.45%	39.52%	191.96%	101.19%	556.32%	795.94%
Haleon Plc - ADR	-0.31%	61.37%	30.23%	30.23%	30.23%	30.23%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

United Therapeutics (UTHR): View Full Stock Overview

Haleon Plc - ADR (HLN): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: United Therapeutics vs Haleon Plc - ADR

Metric	UTHR	HLN
Market Information
Market Cap i	$13.63B	$43.62B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	934,920	8,838,500
90 Day Avg. Volume i	575,800	11,194,110
Last Close	$313.13	$9.65
52 Week Range	$266.98 - $417.82	$8.86 - $11.42
% from 52W High	-25.06%	-15.50%
All-Time High	$417.82 (Nov 04, 2024)	$11.42 (Jun 02, 2025)
% from All-Time High	-25.06%	-15.50%
Growth Metrics
Quarterly Revenue Growth	0.12%	-0.01%
Quarterly Earnings Growth	0.11%	0.33%
Financial Health
Profit Margin (TTM) i	0.40%	0.14%
Operating Margin (TTM) i	0.46%	0.22%
Return on Equity (TTM) i	0.19%	0.09%
Debt to Equity (MRQ) i	0.00	53.41
Cash & Liquidity
Book Value per Share (MRQ)	$158.65	$1.77
Cash per Share (MRQ)	$67.41	$0.08
Operating Cash Flow (TTM) i	$1.37B	$3.37B
Levered Free Cash Flow (TTM) i	$811.05M	$2.61B
Dividends
Last 12-Month Dividend Yield i	N/A	1.63%
Last 12-Month Dividend i	N/A	$0.17

Valuation & Enterprise Metrics Analysis: United Therapeutics vs Haleon Plc - ADR

Metric	UTHR	HLN
Price Ratios
P/E Ratio (TTM) i	11.76	21.44
Forward P/E i	10.81	22.98
PEG Ratio i	1.23	22.98
Price to Sales (TTM) i	4.43	3.96
Price to Book (MRQ) i	1.90	5.44
Market Capitalization
Market Capitalization i	$13.63B	$43.62B
Enterprise Value i	$10.58B	$128.31B
Enterprise Value Metrics
Enterprise to Revenue i	3.44	8.59
Enterprise to EBITDA i	6.63	36.05
Risk & Other Metrics
Beta i	0.57	0.24
Book Value per Share (MRQ) i	$158.65	$1.77

Financial Statements Comparison: United Therapeutics vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	UTHR	HLN
Revenue/Sales i	$794.40M	$2.76B
Cost of Goods Sold i	$92.50M	$1.23B
Gross Profit i	$701.90M	$1.53B
Research & Development i	$149.00M	$78.00M
Operating Income (EBIT) i	$382.80M	$350.00M
EBITDA i	$449.40M	$362.00M
Pre-Tax Income i	$423.50M	$288.00M
Income Tax i	$101.30M	$66.00M
Net Income (Profit) i	$322.20M	$222.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	UTHR	HLN
Cash & Equivalents i	$1.90B	$2.20B
Total Current Assets i	$3.94B	$5.72B
Total Current Liabilities i	$721.50M	$5.81B
Long-Term Debt i	N/A	$8.62B
Total Shareholders Equity i	$6.81B	$16.22B
Retained Earnings i	$7.54B	$27.27B
Property, Plant & Equipment i	$0	$0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	UTHR	HLN
Operating Cash Flow i	$463.80M	N/A
Capital Expenditures i	$-74.90M	N/A
Free Cash Flow i	$386.30M	N/A
Debt Repayment i	$-100.00M	N/A
Common Stock Repurchase i	$0	N/A

Short Interest & Institutional Ownership Analysis

Metric	UTHR	HLN
Shares Short i	1.57M	17.45M
Short Ratio i	3.62	1.39
Short % of Float i	0.05%	0.00%
Average Daily Volume (10 Day) i	934,920	8,838,500
Average Daily Volume (90 Day) i	575,800	11,194,110
Shares Outstanding i	44.83M	12.36B
Float Shares i	41.71M	8.95B
% Held by Insiders i	0.02%	0.00%
% Held by Institutions i	1.00%	0.13%

Dividend Analysis & Yield Comparison: United Therapeutics vs Haleon Plc - ADR

Metric	UTHR	HLN
Last 12-Month Dividend i	N/A	$0.17
Last 12-Month Dividend Yield i	N/A	1.63%
3-Year Avg Annual Dividend i	N/A	$0.11
3-Year Avg Dividend Yield i	N/A	0.91%
3-Year Total Dividends i	N/A	$0.34
Ex-Dividend Date	N/A	Apr 25, 2025

United Therapeutics [UTHR] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison